Emtricitabine/Tenofovir Disoproxil Mylan

Emtricitabine/Tenofovir Disoproxil Mylan is a combination medication used for HIV treatment and prevention. This oral medication is designed to help manage HIV infection and reduce the risk of transmission.

Emtricitabine/Tenofovir Disoproxil Mylan is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals at high risk. This medication works by reducing the amount of HIV in the body, helping to improve immune function and lower the risk of HIV-related complications.

Common effects of Emtricitabine/Tenofovir Disoproxil Mylan may include headache, nausea, diarrhea, and dizziness. Some individuals may also experience fatigue, insomnia, or mild abdominal pain. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Mylan should be used with caution in individuals with kidney problems or a history of bone disorders. Regular monitoring of kidney function and bone density may be recommended. It is important to follow the prescribed dosage and not to share this medication with others.

Emtricitabine/Tenofovir Disoproxil Mylan may interact with other medications, including those used to treat HIV, hepatitis B, and certain antacids. Alcohol consumption should be avoided as it may increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.